SIU Medicine audiologist Jennifer L. Berry, AuD, CCC-A, took the title "Best Audiologist" in the Illinois Times' 2018 Best of Springfield awards. Hundreds of readers took to the internet to cast their votes for their favorite restaurants, health care providers, dry cleaners and more in the annual contest. Berry specializes in treating hearing loss and tinnitus and provides cochlear implant services, hearing screenings and hearing aid services. She joined SIU Medicine's Department of Surgery after spending several years researching hearing loss and tinnitus. Berry sees patients at the Ear Nose

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

Title IX Policy Title IX of the Education Amendments and SIU policy prohibits discrimination in the provisions of services of benefits offered by the University based on gender. Any person (student, faculty or staff) who believes that discriminatory practices have been engaged in based upon gender may discuss their concerns and file complaints of possible violations of Title IX by contacting the following: Kay W. Doan Title IX Coordinator 483 Woody Hall Mail Code 4316 Southern Illinois University Carbondale Carbondale, Illinois 62901 Phone: 618-453-4807 Fax: 618-453-1395 To review the Title IX

On Wednesday, September 19, Southern Illinois University School of Medicine celebrated the new Department of Population Science and Policy with an event attended by SIU Medicine Dean and Provost Dr. Jerry Kruse, Interim SIU System President Dr. Kevin Dorsey, Population Science and Policy staff, friends, community partners and other interested individuals. The event, which featured a reception and informational program, invited people to join the movement of improving health in central and southern Illinois. The program reflected on the genesis of the Department, its work to uphold the school's

SIU School of Medicine Launches Department of Population Science and Policy New department considers social determinants to improve overall health in central, southern Illinois SPRINGFIELD, ILLINOIS, Sept. 18, 2018 – The Department of Population Science and Policy – Southern Illinois University School of Medicine’s first new department in nearly three decades, aims to be a champion for rural Illinoisans. To improve the health and wellness in the 66 counties of central and southern Illinois, the department will identify community-based interventions and study how factors such as poverty, access